From medicalnewstoday.com
()
Day By Day With The PD Warrior
My Trials and tribulations (along with a few rants) about living with young onset Parkinson's disease
Following one of the largest studies ever conducted in Parkinson's disease (PD), researchers at Mount Sinai School of Medicine report in The New England Journal of Medicine that rasagiline, a drug currently used to treat the symptoms of PD, may also slow the rate of disease progression.
More perspectives...
Geneva, Switzerland, 3 November 2009 - Addex Pharmaceuticals (SWX:ADXN), the allosteric modulation company, presented results today from studies of its lead clinical candidate, ADX10059, in animal models of Parkinson's disease levodopa induced dyskinesia (PD-LID) at the Discovery on Target GPCR-based Drug Discovery conference in Boston. Addex disclosed for the first time that in a non-human primate model of PD-LID, ADX10059 had a statistically...
More perspectives...
From ad-hoc-news.de
()
GENEVA, SWITZERLAND -- (Marketwire) -- 11/03/09 --
ADX10059 inhibited both chorea and dystonia induced by levodopa while maintaining the anti-parkinsonian effect of levodopa on PD symptoms
Geneva, Switzerland, 3 November 2009 - Addex Pharmaceuticals (SWISS: ADXN), the allosteric modulation company, presented results today from studies of its lead clinical candidate, ADX10059, in animal models of Parkinson's disease levodopa induced...
More perspectives...
From pr-inside.com
()
Medford, Ore. -- A Medford boy shot himself in the foot with his father's gun Saturday.
Medford police said the four-year-old boy found the gun in the garage.
Police said the injuries are not life threatening and the boy was taken to a local...
More perspectives...
From ktvl.com
()
Following one of the largest studies ever conducted in Parkinson's disease (PD), researchers report that rasagiline, a drug currently used to treat the symptoms of PD, may also slow the rate of disease progression.
More perspectives...
From sciencedaily.com
()
Mutations in the gene for glucocerebrosidase, an enzyme deficient in Gaucher's disease, are also commonly found in PD patients. Carriers have a 5- to 6-fold increased risk for PD. Medscape Medical News
More perspectives...
From medscape.com
()
Sun Life Financial names new investment officerForbesAP , 09.17.09, 02:58 PM EDT TORONTO -- Sun Life Financial Inc. said Thursday it named Stephen C. Peacher its chief investment officer, effective Oct. 13. ...Stephen Peacher Appointed Sun Life Financial's Chief Investment ...ReutersSun Life Lures a Top Columbia ManagerMutualFundWire.comBond chief Peacher leaves Columbia to be Sun Life CIOPensions & InvestmentsComtex Smartrendall 26 news...
More perspectives...
From news.google.com
()

